Brief: DocMorris confirms revenue and EBITDA outlook from March

DocMorris AG

11/07/2024 06:05

July 11 (Reuters) - DocMorris AG  DOCM.S :
    * DOCMORRIS WITH ACCELERATED AND SIGNIFICANT ERX GROWTH IN
NEW
CUSTOMERS, MARKET SHARE AND REVENUE
    * DOCMORRIS AG - 17 PER CENT REVENUE GROWTH OF PRESCRIPTION
MEDICINES (RX) COMPARED TO PREVIOUS QUARTER
    * DOCMORRIS AG - TRIPLING OF NEW RX CUSTOMERS SINCE
INTRODUCTION
OF CARDLINK
    * DOCMORRIS AG - INDICATIVE REVENUE AND EBITDA OUTLOOK FROM
20
MARCH 2024 REMAINS IN PLACE
    * DOCMORRIS AG - AS AT END OF JUNE 2024, NUMBER OF ACTIVE
CUSTOMERS 3  3  INCREASED BY 300,000 TO 10.0 MILLION COMPARED TO
PREVIOUS QUARTER
    * DOCMORRIS AG - EXTERNAL REVENUE GREW BY 6.4 PER CENT IN
LOCAL
CURRENCY IN Q2 OF 2024 COMPARED TO SAME PERIOD OF PREVIOUS YEAR

Source text for Eikon:  ID:nEQ5f4M0Da 
Further company coverage:  DOCM.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com ; +48 58 772 0920))